The Anti-Anxiety Stack: L-Theanine, Magnesium, and Ashwagandha
Everyday anxiety is not one problem. It is at least three: the acute spike before a presentation, the autonomic load that runs all day in your shoulders and jaw, and the slow grind of an over-cranked HPA axis that keeps cortisol elevated past bedtime. A useful stack treats each layer separately rather than dumping a single sedating agent on top of all of them. Below is a three-layer approach with the trial evidence for each component, the doses that have actually been studied, and the cautions that matter.
Foundation: Magnesium Glycinate, 200–300 mg Elemental Nightly
Magnesium is the foundation because deficiency is common (NHANES estimates roughly half of US adults consume less than the EAR) and because the symptoms of low magnesium overlap heavily with the somatic side of anxiety: muscle twitching, palpitations, irritability, light-stage insomnia. A 2017 systematic review of 18 trials concluded that magnesium supplementation had a modest beneficial effect on subjective anxiety in mildly anxious adults and in women with premenstrual symptoms, though the trials were generally small and heterogeneous. The glycinate form is preferred over oxide because elemental absorption is far higher and gastrointestinal tolerance is better at the doses required. Take it with the evening meal, not on an empty stomach, and do not exceed 350 mg of supplemental elemental magnesium daily without checking renal function. See the magnesium dossier for form comparisons and the anxiety condition page for how this layer fits the wider picture.
Acute Layer: L-Theanine, 200 mg as Needed
L-theanine is the on-demand component. It is a non-proteinogenic amino acid from green tea that increases alpha-wave activity on EEG within 30–40 minutes, an electrophysiological signature of relaxed alertness rather than sedation. Multiple acute-dosing RCTs in healthy adults under cognitive or social stressors have shown reductions in subjective stress scales and modest reductions in salivary cortisol at 200 mg single doses; a four-week RCT in 30 adults at the same daily dose found improvements on STAI state anxiety and on sleep quality versus placebo. It does not interact with GABA receptors the way benzodiazepines do, which is why it does not produce tolerance, dependence, or impaired psychomotor function. Useful before a stressful meeting or as a 100 mg morning + 100 mg afternoon split. See the L-theanine and caffeine focus stack for the related daytime use.
HPA Axis Layer: Ashwagandha, 300–600 mg Standardized Extract Daily
Ashwagandha is the layer that addresses chronic, weeks-on-end stress rather than the acute spike. Several RCTs using KSM-66 or Shoden extracts at 300–600 mg daily for 8 weeks have shown statistically significant reductions in Perceived Stress Scale scores and in serum cortisol versus placebo, with effect sizes in the moderate range. A 2021 meta-analysis of 12 RCTs concluded that ashwagandha reduced anxiety scores compared to placebo, though the authors flagged risk of bias and the fact that nearly all positive trials were performed in India by groups with relationships to the extract manufacturers. The signal is real but the effect is probably smaller in practice than the published trials suggest. Cycle 8 weeks on, 2 weeks off, and do not start ashwagandha if you have hyperthyroidism or are on thyroid replacement without endocrinology input — case reports of thyrotoxicosis and a small number of drug-induced liver injury cases have been published since 2019.
What NOT to Add
Kava produces real anxiolysis but carries a documented hepatotoxicity signal that led to bans in several European countries; we do not recommend it in a daily stack. Valerian's anxiolytic evidence is weak and inconsistent in adults; it is more reasonable as an occasional sleep adjunct. CBD has emerging social-anxiety data but the unregulated supplement supply makes dose reliability poor — see our CBD anxiety review for the trial-level picture. Avoid stacking ashwagandha with benzodiazepines, SSRIs, or thyroid replacement without prescriber sign-off.
How to Run the Stack
Start with magnesium alone for two weeks. Add L-theanine 200 mg as-needed on the third week if acute spikes are still a problem. Add ashwagandha 300 mg with breakfast at week four if the chronic-load layer is still active, then reassess at week eight. Track perceived stress on a 0–10 scale daily; a meaningful response is a sustained 2-point drop. If nothing has moved after eight weeks of the full stack, the issue is probably not within the scope of supplementation and a clinical evaluation is the next step. For the related sleep version of this approach, see the evidence-based sleep stack.
Bottom Line
This stack works because the three components address different physiology and have non-overlapping side effect profiles. Magnesium for the somatic and sleep-onset layer, L-theanine for the acute cognitive layer, ashwagandha for the multi-week HPA layer. None of them replace cognitive behavioral therapy or appropriate pharmacotherapy for diagnosed generalized anxiety disorder; they sit underneath those interventions, not in place of them.
Sources
- Boyle NB, Lawton C, Dye L. "The effects of magnesium supplementation on subjective anxiety and stress — a systematic review." Nutrients, 2017;9(5):429. PMID: 28445426. DOI: 10.3390/nu9050429.
- Hidese S, Ogawa S, Ota M, et al. "Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial." Nutrients, 2019;11(10):2362. PMID: 31623400. DOI: 10.3390/nu11102362.
- Kimura K, Ozeki M, Juneja LR, Ohira H. "L-Theanine reduces psychological and physiological stress responses." Biological Psychology, 2007;74(1):39-45. PMID: 16930802. DOI: 10.1016/j.biopsycho.2006.06.006.
- Chandrasekhar K, Kapoor J, Anishetty S. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine, 2012;34(3):255-262. PMID: 23439798. DOI: 10.4103/0253-7176.106022.
- Pratte MA, Nanavati KB, Young V, Morley CP. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera)." Journal of Alternative and Complementary Medicine, 2014;20(12):901-908. PMID: 25405876. DOI: 10.1089/acm.2014.0177.
- Salve J, Pate S, Debnath K, Langade D. "Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study." Cureus, 2019;11(12):e6466. PMID: 32021735. DOI: 10.7759/cureus.6466.
- Ikram MA, Kershaw KN, et al. "Magnesium intake and depression in adults." Journal of the American Board of Family Medicine, 2015;28(2):249-256. PMID: 25748766. DOI: 10.3122/jabfm.2015.02.140176.